Heron Therapeutics Inc vs Ross Stores, Inc. — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $63.41M), while Ross Stores, Inc. trades at $252 (market cap $81.74B). The key difference: Ross Stores, Inc. is far larger — about 1289.1× Heron Therapeutics Inc's market cap, and Ross Stores, Inc. pays a 0.7% dividend while Heron Therapeutics Inc pays none. Which is the better fit depends on your goals.
| HRTX | ROST | |
|---|---|---|
Market Cap | $63.41M | $81.74B |
Sector | Health | Consumer Cyclical |
52-Week High | $1.49 | $255.23 |
52-Week Low | $0.32 | $144.67 |
Enterprise Value | $161.31M | $82.34B |
Dividend Yield | — | 0.7% |
Signals from Pluang's Aura AI — not financial advice
Heron Therapeutics (HRTX) trades at $0.49, down 1.64% today, with a bearish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed earnings expectations with a $0.03 loss per share. Despite negative net income margins, HRTX maintains strong analyst support with 94.7% buy ratings. Recent news highlights patent litigation developments and quarterly earnings underperformance.
HRTX faces significant fundamental challenges with persistent losses and declining revenue projections, though analyst consensus remains overwhelmingly bullish. Investment opportunity exists if the company can achieve profitability and meet growth targets, but risks include ongoing operational losses, competitive pressures, and execution challenges in the biotechnology sector.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →Ross Stores is a leading American off-price apparel and home fashion retailer, operating over 1,920 stores (at the end of fiscal 2021) across the Ross Dress for Less and dd's Discounts banners. Ross offers a variety of name-brand products and targets undercutting conventional retailers' regular prices by 20%-70%. The company uses an opportunistic, flexible merchandising approach
Read more on ROST →